These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36326406)

  • 1. Could lysosomal acid lipase enzyme activity be used for clinical follow-up in cryptogenic cirrhosis?
    Köse E; Çağatay E; Yaraş T; Kısa PT; Güler S; Gülten ZA; Akarsu M; Oktay Y; Kayalı HA; Arslan N
    Turk J Med Sci; 2022 Aug; 52(4):1075-1084. PubMed ID: 36326406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
    Carter A; Brackley SM; Gao J; Mann JP
    J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
    Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M
    World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.
    Angelico F; Corradini SG; Pastori D; Fargion S; Fracanzani AL; Angelico M; Bolondi L; Tozzi G; Pujatti PL; Labbadia G; Corazza GR; Averna M; Perticone F; Croce G; Persico M; Bucci T; Baratta F; Polimeni L; Del Ben M; Violi F;
    Atherosclerosis; 2017 Jul; 262():179-184. PubMed ID: 28396038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.
    Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S
    Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
    Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
    Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.
    Reynolds TM; Mewies C; Hamilton J; Wierzbicki AS;
    J Clin Pathol; 2018 Jul; 71(7):608-613. PubMed ID: 29358478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights.
    Cappuccio G; Donti TR; Hubert L; Sun Q; Elsea SH
    J Inherit Metab Dis; 2019 May; 42(3):509-518. PubMed ID: 30684275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
    Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
    J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
    Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
    J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
    Aslanidis C; Ries S; Fehringer P; Büchler C; Klima H; Schmitz G
    Genomics; 1996 Apr; 33(1):85-93. PubMed ID: 8617513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent insights into lysosomal acid lipase deficiency.
    Korbelius M; Kuentzel KB; Bradić I; Vujić N; Kratky D
    Trends Mol Med; 2023 Jun; 29(6):425-438. PubMed ID: 37028992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
    Civallero G; De Mari J; Bittar C; Burin M; Giugliani R
    Gene; 2014 Apr; 539(1):154-6. PubMed ID: 24508470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.
    Porto AF
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():125-32. PubMed ID: 25345094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?
    Gravito-Soares M; Gravito-Soares E; Gomes D; Tome L
    Ann Hepatol; 2019; 18(1):78-88. PubMed ID: 31113613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare cause of hepatomegaly and dyslipidemia: lysosomal acid lipase deficiency.
    Gürbüz BB; Güney İ; Bulut FD; Dilek O
    Turk J Pediatr; 2020; 62(5):831-835. PubMed ID: 33108087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Form of Metabolic-Associated Fatty Liver Disease Associated with a Novel LIPA Variant.
    Anushiravani A; Jafari Khamirani H; Mohamadkhani A; Mani A; Dianatpour M; Malekzadeh R
    Arch Iran Med; 2023 Feb; 26(2):86-91. PubMed ID: 37543928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
    Fasano T; Pisciotta L; Bocchi L; Guardamagna O; Assandro P; Rabacchi C; Zanoni P; Filocamo M; Bertolini S; Calandra S
    Mol Genet Metab; 2012 Mar; 105(3):450-6. PubMed ID: 22227072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal Acid Lipase in Lipid Metabolism and Beyond.
    Li F; Zhang H
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):850-856. PubMed ID: 30866656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study.
    Mashima R; Takada S
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.